Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder
Lesley L Breech, Paula K BravermanDivision of Adolescent Medicine, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USAAbstract: Premenstrual dysphoric disorder (PMDD) is estimated to affect 3%–...
Saved in:
Main Authors: | Lesley L Breech (Author), Paula K Braverman (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne
by: Jerry KL Tan, et al.
Published: (2009) -
Simultaneous determination of ethinyl estradiol and drospirenone in oral contraceptive by high performance liquid chromatography
by: Viviane Benevenuti Silva, et al.
Published: (2013) -
Simultaneous total occlusion of two coronary arteries associated with use of drospirenone-ethinyl estradiol (oral contraceptive)
by: Hüsnü Atmaca, et al.
Published: (2018) -
Efficacy, safety, and patient acceptability of the etonogestrel and ethinyl estradiol vaginal ring
by: Lete I, et al.
Published: (2014) -
The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 µg/levonorgestrel 100 µg + ethinyl estradiol 10 µg
by: Sheila Krishnan, et al.
Published: (2010)